Risk mining of glaucoma associated with aflibercept and ranibizumab based on the US FDA Adverse Event Reporting System database

doi:10.3969/j.issn.1672-3384.2020.12.003

NIU Zi-ran, ZHAO Bin, LIU Rong-ji, DU Xiao-li

Clinical Medication Journal ›› 2020, Vol. 18 ›› Issue (12) : 12-16.

PDF(738 KB)

Clinical Medication Journal ›› 2020, Vol. 18 ›› Issue (12) : 12-16. DOI: 10.3969/j.issn.1672-3384.2020.12.003

Drug Therapy of Eye Diseases

Risk mining of glaucoma associated with aflibercept and ranibizumab based on the US FDA Adverse Event Reporting System database

{{article.zuoZhe_EN}}

Author information +

History +

HeighLight

Abstract

Key words

QR code of this article

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations

{{article.zuoZheEn_L}}. {{article.title_en}}[J]. {{journal.qiKanMingCheng_EN}}, 2020, 18(12): 12-16 https://doi.org/10.3969/j.issn.1672-3384.2020.12.003

References

List( Publishing order | Descend order by publishing year | Descend order by cited within ) Chart analysis

References

Funding

RIGHTS & PERMISSIONS

PDF(738 KB)

Accesses

Citation

Detail

Sections

Recommended

Received	Published
2020-06-09	2020-12-01
Issue Date
2020-12-01

Please choose a citation manager

Content to export